In recurrent GBM, the phosphatidylinositol 3-kinase (PI3K) pathway activity, driven by macrophage-secreted insulin-like growth factor-1 (IGF-1) and tumor cell IGF-1 receptor (IGF-1R), was increased. This evidence concerns the gene IGF1 and glioblastoma.